Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making

被引:3
作者
Ramasco, Fernando [1 ]
Mendez, Rosa [1 ]
de la Rica, Alejandro Suarez [1 ]
de Castro, Rafael Gonzalez [2 ]
Maseda, Emilio [3 ]
机构
[1] Hosp Univ La Princesa, Dept Anaesthesiol & Surg Intens Care, Diego Leon 62, Madrid 28006, Spain
[2] Univ Hosp Leon, Dept Rheumatol, Leon 24071, Spain
[3] Hosp Univ Fdn Alcorcon, Dept Traumatol & Orthopaed Surg, Madrid, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 01期
关键词
Antimicrobial Stewardship; sparing carbapenems; new antibiotics; antimicrobial resistance; individualization; antibiotic treatment; sepsis; septic shock; Gram negatives; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; CLINICAL MICROBIOLOGY; AMERICAN-COLLEGE; EUROPEAN-SOCIETY;
D O I
10.3390/jpm14010106
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The main recent change observed in the field of critical patient infection has been universal awareness of the need to make better use of antimicrobials, especially for the most serious cases, beyond the application of simple and effective formulas or rigid protocols. The increase in resistant microorganisms, the quantitative increase in major surgeries and interventional procedures in the highest risk patients, and the appearance of a significant number of new antibiotics in recent years (some very specifically directed against certain mechanisms of resistance and others with a broader spectrum of applications) have led us to shift our questions from "what to deal with" to "how to treat". There has been controversy about how best to approach antibiotic treatment of complex cases of sepsis. The individualized and adjusted dosage, the moment of its administration, the objective, and the selection of the regimen are pointed out as factors of special relevance in a critically ill patient where the frequency of resistant microorganisms, especially among the Enterobacterales group, and the emergence of multiple and diverse antibiotic treatment alternatives have made the appropriate choice of antibiotic treatment more complex, requiring a constant updating of knowledge and the creation of multidisciplinary teams to confront new infections that are difficult to treat. In this article, we have reviewed the phenomenon of the emergence of resistance to antibacterials and we have tried to share some of the ideas, such as stewardship, sparing carbapenems, and organizational, microbiological, pharmacological, and knowledge tools, that we have considered most useful and effective for individualized decision making that takes into account the current context of multidrug resistance. The greatest challenge, therefore, of decision making in this context lies in determining an effective, optimal, and balanced empirical antibiotic treatment.
引用
收藏
页数:37
相关论文
共 167 条
  • [31] Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
    De Pascale, Gennaro
    Antonelli, Massimo
    Deschepper, Mieke
    Arvaniti, Kostoula
    Blot, Koen
    Brown, Ben Creagh
    de Lange, Dylan
    De Waele, Jan
    Dikmen, Yalim
    Dimopoulos, George
    Eckmann, Christian
    Francois, Guy
    Girardis, Massimo
    Koulenti, Despoina
    Labeau, Sonia
    Lipman, Jeffrey
    Lipovetsky, Fernando
    Maseda, Emilio
    Montravers, Philippe
    Mikstacki, Adam
    Paiva, Jose-Artur
    Pereyra, Cecilia
    Rello, Jordi
    Timsit, Jean-Francois
    Vogelaers, Dirk
    Blot, Stijn
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (11) : 1593 - 1606
  • [32] Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
    De Pascale, Gennaro
    Lisi, Lucia
    Ciotti, Gabriella Maria Pia
    Vallecoccia, Maria Sole
    Cutuli, Salvatore Lucio
    Cascarano, Laura
    Gelormini, Camilla
    Bello, Giuseppe
    Montini, Luca
    Carelli, Simone
    Di Gravio, Valentina
    Tumbarello, Mario
    Sanguinetti, Maurizio
    Navarra, Pierluigi
    Antonelli, Massimo
    [J]. ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [33] Optimized Treatment of Nosocomial Peritonitis
    De Waele, Jan J.
    Coccolini, Federico
    Lagunes, Leonel
    Maseda, Emilio
    Rausei, Stefano
    Rubio-Perez, Ines
    Theodorakopoulou, Maria
    Arvaniti, Kostoula
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [34] Source control in the management of sepsis and septic shock
    De Waele, Jan J.
    Girardis, Massimo
    Martin-Loeches, Ignacio
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (12) : 1799 - 1802
  • [35] Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts
    De Waele, Jan J.
    Schouten, Jeroen
    Beovic, Bojana
    Tabah, Alexis
    Leone, Marc
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (02) : 236 - 244
  • [36] Multidrug-resistant bacteria in ICU: fact or myth
    De Waele, Jan J.
    Boelens, Jerina
    Leroux-Roels, Isabel
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (02) : 156 - 161
  • [37] Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient
    De Waele, Jan J.
    Dhaese, Sofie
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (02) : 89 - 97
  • [38] The place of new antibiotics for Gram-negative bacterial infections in intensive care: report of a consensus conference
    Dequin, Pierre-Francois
    Aubron, Cecile
    Faure, Henri
    Garot, Denis
    Guillot, Max
    Hamzaoui, Olfa
    Lemiale, Virginie
    Maizel, Julien
    Mootien, Joy Y.
    Osman, David
    Simon, Marie
    Thille, Arnaud W.
    Vinsonneau, Christophe
    Kuteifan, Khaldoun
    [J]. ANNALS OF INTENSIVE CARE, 2023, 13 (01)
  • [39] A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients
    Di Franco, Sveva
    Alfieri, Aniello
    Fiore, Marco
    Fittipaldi, Ciro
    Pota, Vincenzo
    Coppolino, Francesco
    Sansone, Pasquale
    Pace, Maria Caterina
    Passavanti, Maria Beatrice
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [40] Diekema DJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00355-19, 10.1128/aac.00355-19]